M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Intrinsic Value

The intrinsic value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is 86.57 SAR. Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
86.57 SAR
Overvaluation 29%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Middle East Pharmaceutical Industries Company SJSC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Middle East Pharmaceutical Industries Company SJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Middle East Pharmaceutical Industries Company SJSC?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Middle East Pharmaceutical Industries Company SJSC

Provide an overview of the primary business activities
of Middle East Pharmaceutical Industries Company SJSC.

What unique competitive advantages
does Middle East Pharmaceutical Industries Company SJSC hold over its rivals?

What risks and challenges
does Middle East Pharmaceutical Industries Company SJSC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Middle East Pharmaceutical Industries Company SJSC.

Provide P/S
for Middle East Pharmaceutical Industries Company SJSC.

Provide P/E
for Middle East Pharmaceutical Industries Company SJSC.

Provide P/OCF
for Middle East Pharmaceutical Industries Company SJSC.

Provide P/FCFE
for Middle East Pharmaceutical Industries Company SJSC.

Provide P/B
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/S
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/GP
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/EBITDA
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/EBIT
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/OCF
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/FCFF
for Middle East Pharmaceutical Industries Company SJSC.

Provide EV/IC
for Middle East Pharmaceutical Industries Company SJSC.

Show me price targets
for Middle East Pharmaceutical Industries Company SJSC made by professional analysts.

What are the Revenue projections
for Middle East Pharmaceutical Industries Company SJSC?

How accurate were the past Revenue estimates
for Middle East Pharmaceutical Industries Company SJSC?

What are the Net Income projections
for Middle East Pharmaceutical Industries Company SJSC?

How accurate were the past Net Income estimates
for Middle East Pharmaceutical Industries Company SJSC?

What are the EPS projections
for Middle East Pharmaceutical Industries Company SJSC?

How accurate were the past EPS estimates
for Middle East Pharmaceutical Industries Company SJSC?

What are the EBIT projections
for Middle East Pharmaceutical Industries Company SJSC?

How accurate were the past EBIT estimates
for Middle East Pharmaceutical Industries Company SJSC?

Compare the revenue forecasts
for Middle East Pharmaceutical Industries Company SJSC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Middle East Pharmaceutical Industries Company SJSC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Middle East Pharmaceutical Industries Company SJSC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Middle East Pharmaceutical Industries Company SJSC compared to its peers.

Compare the P/E ratios
of Middle East Pharmaceutical Industries Company SJSC against its peers.

Discuss the investment returns and shareholder value creation
comparing Middle East Pharmaceutical Industries Company SJSC with its peers.

Analyze the financial leverage
of Middle East Pharmaceutical Industries Company SJSC compared to its main competitors.

Show all profitability ratios
for Middle East Pharmaceutical Industries Company SJSC.

Provide ROE
for Middle East Pharmaceutical Industries Company SJSC.

Provide ROA
for Middle East Pharmaceutical Industries Company SJSC.

Provide ROIC
for Middle East Pharmaceutical Industries Company SJSC.

Provide ROCE
for Middle East Pharmaceutical Industries Company SJSC.

Provide Gross Margin
for Middle East Pharmaceutical Industries Company SJSC.

Provide Operating Margin
for Middle East Pharmaceutical Industries Company SJSC.

Provide Net Margin
for Middle East Pharmaceutical Industries Company SJSC.

Provide FCF Margin
for Middle East Pharmaceutical Industries Company SJSC.

Show all solvency ratios
for Middle East Pharmaceutical Industries Company SJSC.

Provide D/E Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide D/A Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide Interest Coverage Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide Altman Z-Score Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide Quick Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide Current Ratio
for Middle East Pharmaceutical Industries Company SJSC.

Provide Cash Ratio
for Middle East Pharmaceutical Industries Company SJSC.

What is the historical Revenue growth
over the last 5 years for Middle East Pharmaceutical Industries Company SJSC?

What is the historical Net Income growth
over the last 5 years for Middle East Pharmaceutical Industries Company SJSC?

What is the current Free Cash Flow
of Middle East Pharmaceutical Industries Company SJSC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Middle East Pharmaceutical Industries Company SJSC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Middle East Pharmaceutical Industries Company SJSC

Balance Sheet Decomposition
Middle East Pharmaceutical Industries Company SJSC

Current Assets 284.9m
Cash & Short-Term Investments 34.5m
Receivables 153.9m
Other Current Assets 96.5m
Non-Current Assets 170.9m
Long-Term Investments 1.1m
PP&E 122.1m
Intangibles 47.8m
Current Liabilities 116.7m
Accounts Payable 34.1m
Accrued Liabilities 24.1m
Short-Term Debt 40.9m
Other Current Liabilities 17.5m
Non-Current Liabilities 23.7m
Long-Term Debt 1.6m
Other Non-Current Liabilities 22.1m
Efficiency

Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC

Revenue
515.4m SAR
Cost of Revenue
-197.2m SAR
Gross Profit
318.2m SAR
Operating Expenses
-203.1m SAR
Operating Income
115.1m SAR
Other Expenses
-18.1m SAR
Net Income
97m SAR

Free Cash Flow Analysis
Middle East Pharmaceutical Industries Company SJSC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Middle East Pharmaceutical Industries Company SJSC's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive 3-Year Average ROIC
68/100
Profitability
Score

Middle East Pharmaceutical Industries Company SJSC's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Middle East Pharmaceutical Industries Company SJSC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
87/100
Solvency
Score

Middle East Pharmaceutical Industries Company SJSC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC

Wall Street analysts forecast Middle East Pharmaceutical Industries Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 133.62 SAR with a low forecast of 132.31 SAR and a high forecast of 137.55 SAR.

Lowest
Price Target
132.31 SAR
9% Upside
Average
Price Target
133.62 SAR
10% Upside
Highest
Price Target
137.55 SAR
13% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Middle East Pharmaceutical Industries Company SJSC?

Click here to dive deeper.

Dividends

Middle East Pharmaceutical Industries Company SJSC
does not pay dividends
Shareholder Yield

Current shareholder yield for Middle East Pharmaceutical Industries Company SJSC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Middle East Pharmaceutical Industries Company SJSC

Country

Saudi Arabia

Industry

Pharmaceuticals

Market Cap

2.4B SAR

Dividend Yield

0%

Description

Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.

Contact

RIYADH
Riyadh
Second Industrial City,, P.O. Box 3800
+966112653948
www.avalonpharmaceutical.com

IPO

2024-02-27

Employees

335

Officers

See Also

Discover More
What is the Intrinsic Value of one Middle East Pharmaceutical Industries Company SJSC stock?

The intrinsic value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is 86.57 SAR.

Is Middle East Pharmaceutical Industries Company SJSC stock undervalued or overvalued?

Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is Overvalued by 29%.

Back to Top